{"id":341042,"date":"2026-11-05T20:51:43","date_gmt":"2026-11-05T15:21:43","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/windlas-biotech-q2-results-fy27-pat-18-crore\/"},"modified":"2026-11-05T20:51:43","modified_gmt":"2026-11-05T15:21:43","slug":"windlas-biotech-q2-results-fy27-pat-18-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/windlas-biotech-q2-results-fy27-pat-18-crore\/","title":{"rendered":"Windlas Biotech Q2 Results FY27: PAT Rises 1.4% to Rs 18.05 Cr, Revenue Rs 263.91 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Windlas Biotech Q2 Results FY27 were declared on 5 November 2026 on a standalone basis. The quarterly results show revenue of Rs 263.91 Cr against Rs 222.4 Cr in the same quarter last year, a YoY growth of 18.66%. Net profit was Rs 18.05 Cr against Rs 17.8 Cr, up 1.4%, while Operating Profit stood at Rs 29.37 Cr.<\/p>\n<\/div>\n

Windlas Biotech Ltd<\/a> (WINDLAS) Q2 Results FY27 announced on 5 November 2026, covering the company’s financial performance for the July to September quarter. The results date brought standalone revenue of Rs 263.91 Cr and PAT of Rs 18.05 Cr, and Windlas Biotech Q2 Results FY27 are shown on the standalone results basis against the July to September 2025 quarter.<\/p>\n

This Windlas Biotech Q2 Results results analysis covers the financial highlights, the business factors, the outlook and the risks. The section below places revenue, Operating Profit and net profit next to the figures for the same quarter a year earlier.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n